TACI can bind to both BAFF/BLyS and the proliferation-inducing ligand (APRIL) and was tested in moderate-to-severe Chinese SLE patients in a phase 3 clinical study (69). The gene discussed is TNFSF13; the disease is systemic lupus erythematosus.